Management of Recurrent Vaginal and Throat Yeast Infections
Diagnostic Approach
- The diagnosis of recurrent vaginal and throat yeast infections should be confirmed with wet-mount preparation using saline and 10% potassium hydroxide to demonstrate yeast or hyphae, and verify normal vaginal pH (4.0-4.5) 1
- Vaginal cultures should be obtained to identify the specific Candida species, particularly to rule out non-albicans species such as C. glabrata which may be resistant to fluconazole 2, 3
- For oropharyngeal candidiasis, clinical examination should be supplemented with culture to identify potentially resistant organisms 4
Treatment Based on Suspected Organism
- For fluconazole-resistant C. albicans vaginal infections, itraconazole solution 200 mg once daily for up to 28 days may be effective 3
- For fluconazole-resistant C. albicans oropharyngeal infections, itraconazole solution 200 mg once daily 6, 7 or posaconazole suspension 400 mg twice daily for 3 days then 400 mg daily 5 may be effective
- For C. glabrata infections, topical intravaginal boric acid 600 mg daily for 14 days or nystatin intravaginal suppositories 100,000 units daily for 14 days may be effective 2
Maintenance Therapy After Initial Control
- After achieving initial control with induction therapy, maintenance therapy with fluconazole 150 mg weekly for 6 months may be effective for vaginal candidiasis 1
- For recurrent oropharyngeal thrush, chronic suppressive therapy with fluconazole 100 mg three times weekly may be effective 4
- If fluconazole resistance is suspected, consider alternative agents such as itraconazole solution or posaconazole 5
Special Considerations
- Uncontrolled diabetes may contribute to persistent recurrence of yeast infections 4
- Immunodeficiency states may require investigation in patients with persistent recurrence 4
- Proper denture hygiene and disinfection is essential for denture wearers with oral thrush 4
Monitoring and Follow-up
- Monitor for symptom recurrence after completion of maintenance therapy 1
- If symptoms recur after completing the 6-month regimen, consider restarting the maintenance regimen 1
- For patients on long-term azole therapy, monitor for potential hepatotoxicity with periodic liver function tests 6, 7